» Articles » PMID: 29887788

Using a New Marker Clip System in Breast Cancer: Tumark Vision® Clip - Feasibility Testing in Everyday Clinical Practice

Overview
Publisher Karger
Date 2018 Jun 12
PMID 29887788
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study presents first feasibility experiences with a new 3-dimensional (3D) marker clip system in clinical practice. The rate of clinical complete responses in the treatment of breast cancer patients is increasing; additionally, a change to targeted axillary dissection is being considered after neoadjuvant chemotherapy (NACT). Consequently, marker clips are needed which are reliable and easy to handle even in the axillary lymph node system.

Methods: A total of 50 patients from the Breast Care Unit of the Kliniken Essen Mitte were included. Clip marking of all 50 primary breast cancer lesions as well as 23 lymph nodes was performed using the Tumark Vision® clip. Following application, the position and visibility of the marker clip were monitored and documented in 2 axes.

Results: The feasibility of the Tumark Vision clip was excellent in everyday clinical practice as none of the markers dislocated. After clip marking of the tumor region and/or suspicious lymph nodes, all Tumark Vision clips could be detected in both axes. The 3D shape could be observed in all cases after application.

Conclusion: The new 3D-shaped marker clip seems to be a promising tool for marking breast cancer lesions and even lymph nodes before NACT. As there are many studies ongoing to prove the feasibility of a shift from standard axillary dissection after NACT towards targeted axillary dissection, the Tumark Vision clip seems to provide good visibility even in lymph nodes after NACT. Further studies are warranted.

Citing Articles

Targeted axillary dissection using carbon marking for patients with node-positive breast cancer following neoadjuvant therapy (TADCOM): study protocol for a prospective, multicenter, randomized controlled trial.

Chen W, Pang L, Jin X, Chen H, Huang J BMC Cancer. 2024; 24(1):1276.

PMID: 39402559 PMC: 11479563. DOI: 10.1186/s12885-024-13001-2.


The Evaluation of a Cost-Effective Method for Tumour Marking Prior to Neo-Adjuvant Chemotherapy Using Silver Rods.

Hossam A, El-Badrawy A, Khater A, Setit A, Roshdy S, Abdelwahab K Eur J Breast Health. 2023; 19(1):99-105.

PMID: 36605477 PMC: 9806934. DOI: 10.4274/ejbh.galenos.2022.2022-10-3.


Surgery after Neoadjuvant Chemotherapy: A Clip-Based Technique to Improve Surgical Outcomes, a Single-Center Experience.

Minella C, Villasco A, DAlonzo M, Cellini L, Accomasso F, Actis S Cancers (Basel). 2022; 14(9).

PMID: 35565357 PMC: 9103394. DOI: 10.3390/cancers14092229.


Application of ultrasound-guided placement of markers for locating axillary lymph nodes of breast cancer.

Ji X, Wei M, Wang L, Li J, Gao D, Geng C Gland Surg. 2021; 10(11):3067-3074.

PMID: 34926222 PMC: 8637064. DOI: 10.21037/gs-21-598.


Evaluation of sonographic detectability of different markers within an in vitro simulation model of the axilla.

Guergan S, Hoopmann U, Roehm C, Boeer B, Fugunt R, Helms G Arch Gynecol Obstet. 2021; 304(3):839-848.

PMID: 34142225 PMC: 8325667. DOI: 10.1007/s00404-021-06085-9.


References
1.
Esserman L, Cura M, Dacosta D . Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy. Radiographics. 2004; 24(1):147-56. DOI: 10.1148/rg.241035052. View

2.
Dash N, Chafin S, Johnson R, Contractor F . Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer. AJR Am J Roentgenol. 1999; 173(4):911-7. DOI: 10.2214/ajr.173.4.10511147. View

3.
Livaudais-Toman J, Karliner L, Tice J, Kerlikowske K, Gregorich S, Perez-Stable E . Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Breast. 2015; 24(6):758-66. PMC: 4698352. DOI: 10.1016/j.breast.2015.09.009. View

4.
Sakamoto N, Ogawa Y, Tsunoda Y, Fukuma E . Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (UltraClip) placed in phantoms and patients. Breast Cancer. 2016; 24(4):585-592. DOI: 10.1007/s12282-016-0741-0. View

5.
Cortazar P, Zhang L, Untch M, Mehta K, Costantino J, Wolmark N . Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014; 384(9938):164-72. DOI: 10.1016/S0140-6736(13)62422-8. View